RecruitingNCT02954419

IgA Nephropathy Biomarkers Evaluation Study (INTEREST)


Sponsor

Sun Yat-sen University

Enrollment

2,000 participants

Start Date

Nov 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective cohort study is designed to examine the association between blood and urine biomarkers (including genetic variants) and long-term kidney disease progression among 2000 Chinese IgA nephropathy patients with relatively normal kidney function (eGFR≥60 ml/min/1.73 m2).


Eligibility

Min Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No intervention for people with glomerular diseases and iga nephropathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 14 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

No intervention


Locations(1)

The First Affiliated Hospital,Sun Yat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02954419


Related Trials